Review of HPB Cancer Quality Performance Indicators Consultation
Feedback updated 29 Jul 2022
We asked
On 20th January 2020, the Scottish Government published a four week consultation seeking the views on the Draft Revised HPB Cancer Quality Performance Indicators (QPIs).
HPB Cancer QPIs were first published in August 2012 and are subject to formal review every 3 years following analysis of national comparative data. This ensures the success of the National Cancer QPIs in driving quality improvement by remaining clinically relevant and focussing on areas which will result in improvements to the quality of patient care.
During the engagement process views were sought on the revised QPIs that had been developed on:
- The appropriateness of the QPIs that have been developed;
- The target levels that had been set;
- Practical issues surrounding measurement of QPIs or data collection.
You said
The consultation was widely distributed and 11 responses were received to the consultation. These included responses from 9 clinical colleagues and 2 UK charities. All feedback received was reviewed and discussed by the Formal Review group and changes were made prior to the revised QPIs being published.
We did
The final HPB Cancer QPIs were published on the Healthcare Improvement Scotland website:
Cancer Quality Performance Indicators (QPIs) (healthcareimprovementscotland.org)
The responses along with a copy of the final HPB cancer QPI document were circulated to clinical and management colleagues from across NHSScotland, patients affected by HPB cancer and the wider public as well as those who participated in the consultation.
Overview
Under the auspices of the Scottish Cancer Taskforce, National Cancer Quality Performance Indicators (QPIs) were developed to drive continuous quality improvement in cancer care across NHSScotland. In August 2012, HPB Cancer QPIs were published, and following 3 years of national comparative data, these have now been subject to formal review. In order to ensure success of the National Cancer QPIs in driving quality improvement it is critical that QPIs continue to be clinically relevant and focus on areas which will result in improvements to the quality of patient care.
Why your views matter
Wide clinical and public engagement is crucial to ensure wide inclusiveness of clinical colleagues across NHSScotland. It is also vital to include the patients and the public as key stakeholders in this consultation to ensure the acceptability of the QPIs. We would like your comments on the Revised HPB Cancer QPIs. In particular we would like to hear your views on:
- The appropriateness of the QPIs that have been developed.
- The target levels that have been set.
- Key points or areas that are not covered within the QPIs
- Feasibility of measuring the QPIs identified in a meaningful and comparative way (i.e. ‘like for like’ comparison)
Forms to assist with submission of comments have been developed and should be used wherever possible. Please note that supporting evidence should be detailed along with comments where appropriate.
What happens next
All responses will be collated for review and decision by the HPB Cancer QPI Review Group. Those who have participated in the engagement process will receive an overview of the changes made and a copy of the final HPB Cancer QPI document, ahead of publication in 2017.
Interests
- Health and Social Care
Share
Share on Twitter Share on Facebook